Jefferies Financial Group Inc. Adma Biologics, Inc. Transaction History

Jefferies Financial Group Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$5.98 - $11.18 $1.48 Million - $2.77 Million	-248,000 Reduced 73.81%	88,000 $983,000
Q1 2024 May 13, 2024	SELL	$4.4 - $6.74 $8.47 Million - $13 Million	-1,924,000 Reduced 85.13%	336,000 $2.22 Million
Q4 2023 Feb 13, 2024	BUY	$3.08 - $4.52 $6.96 Million - $10.2 Million	2,260,000 New	2,260,000 $10.2 Million

318

184M

917K

91.6K

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.76B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

Stay updated on Jefferies Financial Group Inc. with notifications on news.